Table of Contents  
REVIEW
Year : 2014  |  Volume : 16  |  Issue : 1  |  Page : 101-106

Management of primary ciliary dyskinesia/Kartagener's syndrome in infertile male patients and current progress in defining the underlying genetic mechanism


Reproductive Medicine Center, Maternal and Child Health Hospital of Xiamen, Xiamen, China

Date of Submission18-Feb-2013
Date of Decision28-Jun-2013
Date of Acceptance03-Sep-2013
Date of Web Publication16-Dec-2013

Correspondence Address:
Ping Li
Reproductive Medicine Center, Maternal and Child Health Hospital of Xiamen, Xiamen
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1008-682X.122192

Rights and Permissions
  Abstract 

Kartagener's syndrome (KS) is an autosomal recessive genetic disease accounting for approximately 50% of the cases of primary ciliary dyskinesia (PCD). As it is accompanied by many complications, PCD/KS severely affects the patient's quality of life. Therapeutic approaches for PCD/KS aim to enhance prevention, facilitate rapid definitive diagnosis, avoid misdiagnosis, maintain active treatment, control infection and postpone the development of lesions. In male patients, sperm flagella may show impairment in or complete absence of the ability to swing, which ultimately results in male infertility. Assisted reproductive technology will certainly benefit such patients. For PCD/KS patients with completely immotile sperm, intracytoplasmic sperm injection may be very important and even indispensable. Considering the number of PCD/KS susceptibility genes and mutations that are being identified, more extensive genetic screening is indispensable in patients with these diseases. Moreover, further studies into the potential molecular mechanisms of these diseases are required. In this review, we summarize the available information on various aspects of this disease in order to delineate the therapeutic objectives more clearly, and clarify the efficacy of assisted reproductive technology as a means of treatment for patients with PCD/KS-associated infertility.

Keywords: assisted reproductive technology; clinical diagnosis and treatment; genetic mechanism; Kartagener′s syndrome; male fertility, primary ciliary dyskinesia


How to cite this article:
Sha YW, Ding L, Li P. Management of primary ciliary dyskinesia/Kartagener's syndrome in infertile male patients and current progress in defining the underlying genetic mechanism. Asian J Androl 2014;16:101-6

How to cite this URL:
Sha YW, Ding L, Li P. Management of primary ciliary dyskinesia/Kartagener's syndrome in infertile male patients and current progress in defining the underlying genetic mechanism. Asian J Androl [serial online] 2014 [cited 2017 Aug 18];16:101-6. Available from: http://www.ajandrology.com/text.asp?2014/16/1/101/122192 - DOI: 10.4103/1008-682X.122192


  Introduction Top


In 1933, Kartagener for the first time reported four patients with 'sinusitis-bronchiectasis-situs inversus syndrome' and emphasized that this 'clinical triad' was a special kind of congenital syndrome with familial and hereditary characteristics. Therefore, the syndrome presenting all three symptoms was named complete Kartagener's Syndrome (KS). Another term, incomplete KS, was used to describe cases that did not involve situs inversus. [1],[2],[3]

A previous study has revealed some defects of the ciliary dynein arm in the airway epithelial cells of KS patients. [4] These defects may be related to the decreased mucosal scavenging capability and the absence of ciliary motility in KS. In 1988, Rossman and Newhouse [5] suggested a more appropriate nomenclature for this condition, i.e. primary ciliary dyskinesia (PCD). Generally, PCD encompasses all congenital ciliary dysfunctions, and the term 'KS' can still be used for describing the syndrome accompanied by situs inversus. KS is an autosomal recessive genetic disease accounting for approximately 50% of the cases of PCD. It is one of the most serious subtypes of PCD as it is caused by simultaneous abnormal ciliary function in several parts of the organism. [6],[7],[8]

In this review, we first discuss the incidence and various clinical manifestations of PCD/KS. Then, we present the probable molecular mechanism underlying this disease by summarizing the information on the known predisposing genes and the recent progress made in this field. Next, we summarize the diagnostic and therapeutic approaches employed for PCD/KS on the basis of its partially understood pathoetiology. Throughout these sections, we have discussed several complications associated with PCD/KS, including the causal link between PCD/KS and male infertility, and we briefly point out appropriate treatment approaches for these complications.


  Incidence and Clinical Manifestations of Primary Ciliary Dyskinesia/ Kartagener's Syndrome Top


KS is a rare clinical disease. Its overall incidence is approximately 1/40 000, and it occurs in about 1% of cases of bronchiectasis and 20% of cases of situs inversus. The general age of onset is 10 -0 29 year, and most of the patients are school-aged children or adolescents younger than 15 years of age. However, there is no significant difference in the incidence between males and females. [2],[9]

Cilia are widely present in a variety of tissues and organs, such as the organs of the respiratory tract, paranasal sinuses, Eustachian tube, middle ear, oviduct, spermaductus, flagella of the sperm tail, brain and spinal cord ependyma. Therefore, clinical PCD/KS may not merely exhibit the typical 'clinical triad', but may often be accompanied by a variety of malformations or complications. The most common complications include congenital heart disease, hydrocephalus, cleft palate, bilateral cervical ribs, anal atresia, urethral crack and duplex kidney. In addition, PCD/KS may be complicated by pulmonary heart disease, [10] acute mesangial proliferative glomerulonephritis, [11] renal cell adenocarcinoma, [12] central giant cell granuloma, [13] mediastinal tumor, [14] amyotrophic lateral sclerosis, [15] pulmonary hypertension/pulmonary capillary hemangioma, [16] diffuse bronchiolitis, [17] rheumatoid arthritis, [18] congenital glaucoma/cataracts, nearsightedness, membranous pupil, olfactory defects, serous mucinous otitis, [19] hearing loss, conductive deafness, nephrogenic bone defects, [20] pulmonary infundibular stenosis, chronic kidney failure, [21] reproductive tract abnormalities, testicular seminoma, [22] mental retardation, schizophrenia, [23],[24] neonatal respiratory distress [25],[26],[27] and so on. Ciliary dysfunction in the oviduct or endometrium may lead to an increasing risk of ectopic pregnancy or infertility in women. [3],[28],[29] Sperm flagellum is also a type of cilia. Therefore, abnormal ciliary structure may lead to the reduction or loss of the ability of the flagellum to swing, ultimately causing male infertility.


  Pathophysiology and the Role of Genetic Factors Top


The normal ultrastructural arrangement of cilia shows a typical '9 + 2' pattern: in cross-section, two central and nine pairs of peripheral microtubules can be observed by electron microscopy. All these units are linked by the following three structures. (i) A nexin link, viz., an elastic bridge linking consecutive microtubules, which plays a role in stabilizing the axoneme. (ii) Dynein arms, which allow the nine pairs of microtubules to slide against each other, resulting in a swing of the flagellum. The outer dynein arm (ODA) and the inner dynein arm (IDA) extend from the peripheral microtubules, which are connected by nexin links. (iii) Radiating spokes, which connect central microtubules with peripheral microtubules and change the distance between the peripheral microtubules and the center sheath so as to prevent excessive bending of the flagellum. Together, these structures play an important role in maintaining the overall structure of the flagellum.

A variety of structural defects inside the cilia have been found in patients with PCD/KS by electron microscopy. These defects involve abnormal radiating spokes, microtubular structure, ODA/IDA and so on. These defects are always consistent with the morphological performance of the stunted cilia, including abnormalities of the number (including absence) or structure (such as heterotopia, shortening) of the units mentioned above. [30],[31] Currently, the known defects of cilia can be broadly divided into the following categories: (i) abnormalities of dynein arms, which occur most commonly [32] and include partial or complete absence of ODA/IDA, [33] (ii) abnormalities of radiating spokes, including the absence of spokes or centrotheca or deviated central microtubules, (iii) inappropriate directionality of cilia because of the partial or complete absence of the central microtubules [33] and (iv) abnormal number of peripheral microtubules. Atypical structures such as 8 + 1, 8 + 2, 8 + 3 or 7 + 2 have been observed on cross-section in some parts of histology. As more and more types of defects are found, more scientific classifications are being explored. [34] These defects of stunted cilia are usually the genotype determined characteristics of the patients, but secondary local anomalies caused by inflammation also cannot be ruled out completely in some cases.

During normal embryonic and fetal life, the rotation of various organs is specifically directed and determined by certain genetic factors. In this process, cilia facilitate the correct orientation of viscera sinus in the embryo by swinging in a certain direction. However, in the presence of ciliary disorders, this directional rotation may become random, which may result in malrotation of various organs. Partial or complete situs inversus may result in this manner. [35] In addition, congenital systemic structural and functional abnormalities of cilia always result in defective ciliary clearing function, causing the retention of secretions or bacteria. Inflammation may also be initiated by blockage of the sinus apertures. Persistent or recurrent infections cause bronchiectasis or sinusitis, thus forming part of the pathological basis of KS.

The pathophysiology of PCD/KS is based on poor ciliary movement, which results from genetic defects of ciliary function. [36],[37] Cilia contain a variety of structural proteins or regulatory proteins, and even only the axoneme is composed of more than 130 types of polypeptides; hence, hundreds of genes control these proteins. Theoretically, any mutation of related genes may eventually lead to the formation of dysfunctional cilia, which also reflects the genetic heterogeneity of PCD/KS patients. [38],[39] For this reason, in the decades following recognition of PCD/KS as a clinical entity, many molecular genetic approaches have been applied for the following purposes:(i) to screen and identify candidate genes associated with the disease; (ii) to localize the candidate region of the PCD/KS-related genes in the genome; [40],[41],[42] and (iii) to investigate the relationships between the functions of these genes (including their mutations) and the different phenotypes of PCD/KS patients. [43]

The axonemal dynein intermediate chain gene, DNAI1 (located on chromosome 9p12 -0 21), and the axonemal dynein heavy chain gene, DNAH5 (located on chromosome 5p15 -0 14), are two of the best studied genes in PCD/KS. Mutations in these genes may result in absence of ODA, leading to abnormalities of ciliary ultrastructure and motor function. [31],[44],[45],[46],[47] A number of studies have shown the relationship between genetic mutation and PCD/KS phenotypes, thus driving the investigation of the underlying pathologic mechanism. Guichard et al.[48] performed mutation screening of DNAI1 in 34 KS patients; they identified gene defects in DNAI1 in three independent patients, and the family members of two of these patients also suffered from PCD without situs inversus viscerum. This study demonstrated the association between ciliary function and the localization of organs. In 2002, Ibanez-Tallon et al. [49] established a model of Dnah5 defects in mice. After insertional mutagenesis, these animals presented with a variety of PCD exosyndromes, particularly hydrocephalus. Moreover, the absence of ODA in these animals could be clearly observed under electron microscopy. These results indicated that mutation of Dnah5 was one of the major factors leading to PCD and provided direct evidence for the pathogenesis of hydrocephalus.

Besides DNAI1 and DNAH5, other similar genes have been identified and studied in recent years. Dynein intermediate chain 2 (DNAI2) may be a candidate gene for PCD/KS according to a report by Pennarun et al. [50] It comprises 14 exons, is located on 17q25, and is highly expressed in the trachea and testes. In 2001, the complete cDNA and genomic sequences of axonemal beta heavy chain dynein (DNAH9) were first reported by Bartoloni et al.[51] In 2002, the same group reported that mutations in axonemal heavy chain dynein type 11 (DNAH11) may lead to PCD/KS-related symptoms. They also pointed out that KS may be related to paternal uniparental disomy of chromosome 7. [8] In 2008, Schwabe et al. [52] confirmed this view, but emphasized the possibility of retaining normal axonemal ultrastructure and male fertility when nonsense mutations in DNAH11 occurred. In 2011, Mazor et al. [53] reported a homozygous point mutation of axonemal dynein light chain 1 (DNAL1), viz. NM_031427.3: c.449A> G; p.Asn 150Ser. The occurrence of this mutation reduced the stability of DNAL1 and altered the correlation between this protein and the dynein heavy chain/microtubule. PCD may consequently result with absent or substantially shortened ODA. After identifying mutations in DNAAF3 (also known as PF22), Mitchison et al. [54] suggested that DNAAF3 plays an important role in the pre-assemblage of the dynein complex prior to the formation of cilia. The packing of an active cilia-dynein complex in the cytoplasm may follow a conserved, step-wise process, which is similar to the findings for some other pre-assembled proteins, such as DNAAF2 (also known as PF13 or KTU) and DNAAF1 (also known ODA7 or LRRC50). [54],[55]

Apart from axoneme-related genes, several other candidate genes for PCD/KS have been screened for mutations and studied in order to clarify their physiological functions. [56],[57],[58],[59] DNA polymerase lambda (Pol lambda, also known as Pol beta 2), a member of the DNA polymerase X family, has 32% homology with DNA Pol beta at the amino acid level. In 2002, Kobayashi et al. [60] prepared Pol lambda (-/-) knockout mice utilizing homologous recombination technology. The embryonic development of these mice appeared to be normal; however, most of them showed hydrocephalus with characteristic lateral ventricle expansion, resulting in high postnatal mortality. The surviving individuals always suffered from chronic purulent sinusitis accompanied by visceral translocation; males were sterile because of motionless sperm. Normal offspring could be produced through intracytoplasmic sperm injection (ICSI), suggesting that meiosis was not affected, but ultrastructural analysis showed that the IDA of the ependymal cells and respiratory epithelial cells were not intact, which may be the basis of the disease. Zariwala et al. [61] identified Dpcd as a candidate gene for PCD. In 2002, Pennarun et al. [62] isolated human PF20 and screened this gene in five patients with abnormal ciliary structure. Human PF20 showed homology to Chlamydomonas PF20. Furthermore, adenylate kinase 7 (AK7) provides energy for the beating of cilia via conversion of adenylic acids (2ADP = ATP + AMP). In 2010, Milara et al. [63] measured AK7 expression by real-time PCR and western blotting and investigated its effect on the ciliary beat frequency by siRNA experiments. They also evaluated the motility and ultrastructure of cilia in 29 PCD/KS patients and 26 healthy people, and found that the expression of AK7 was related to ciliary beat frequency, which may be a cause of ciliary dysfunction in PCD/KS patients. A study by Mata et al. [64] in 2012 also found two mutations on AK7 in PCD/KS patients; viz., a previously reported single-nucleotide polymorphism (rs 2369679) and a novel mutation, c.1214insT, which may also be associated with PCD/KS.

In 2011, Geremek et al. [65] generated genome-wide gene expression profiles using bronchial extractions from a PCD patient and identified many genes highly related to PCD by employing a quality-threshold clustering algorithm. Of the 372 genes identified,164 were known, strongly suggesting that the remaining 208 may be new cilia-related genes, which provides a number of candidates for investigation in PCD/KS. However, it is likely that not all mutations in these genes will cause abnormal ciliary movement, which indirectly reflects the intrinsically complex link between genetic variation and morbid phenotype. [66],[67],[68]


  Diagnosis Top


In practice, the clinical diagnosis of PCD/KS is not difficult. The main clinical manifestations of the condition include recurrent chronic cough, sputum, nasal congestion, nasal discharge, hemoptysis and other symptoms of respiratory infections. [3],[69] The incidence of PCD/KS among the offspring of consanguineous marriages is about 20% -0 30%; the incidence is especially pronounced in Caucasians. PCD is a congenital, clinically and ultrastructurally heterogeneous disease due to abnormal structure and/or function of cilia, and KS is an autosomal recessive genetic disease accounting for approximately 50% of the cases of PCD. It may recur in the same generation or show an inter-generational familial hereditary tendency. [70] Accordingly, the parents of patients may have a consanguineous or inter-generational marital history and the patients' brothers or sisters may also suffer from PCD/KS. Therefore, the acquisition of detailed, relevant information is crucial. [71]

Imaging investigation is one of the important methods in the diagnosis of KS. [72] In order to confirm whether bronchiectasis or sinusitis, both of which are important clues for the diagnosis of KS, are present, some auxiliary examination of the chest or sinuses may be needed, depending on the clinical manifestations. Imaging diagnosis of bronchiectasis and sinusitis is relatively easy because these are common diseases. Dextrocardia is the main basis for imaging diagnosis of PCD/KS, because it is the most essential sign of the syndrome. Dextrocardia may be associated with the reversal of the S-shaped heart tube during embryonic development, and it is easily discovered by means of radiography.

In addition to imaging investigation, biopsies of the nasal or airway mucosa may contribute to the diagnosis of PCD/KS. However, artificial secondary ciliary damage must be avoided by obtaining the biopsy materials from the relatively healthy parts of the patient in a stable state. A culture of ciliated epithelial cells may also be required. [73],[74] If ultrastructural defects inside the cilia are observed under scanning electron microscopy or transmission electron microscopy, and if these defects have the morphological appearance of ciliary dysplasia, PCD can be diagnosed. [75] The cilia of patients with other mucus clearance defects have no ultrastructural defects, but do demonstrate decreased oscillatory frequency or abnormal arrangement patterns in their internal structure. [76] Given that the clinical manifestations of these patients may not be obvious or typical, some noninvasive examinations should be considered, such as a saccharin experiment or the measurement of nitric oxide concentrations in exhaled nasal air. [31],[76],[77],[78],[79] For instance, if the concentration of nasal nitric oxide is substantially lower than control values, PCD/KS is more likely to be positively diagnosed. [73] Another technique, the pulmonary radioaerosol mucociliary clearance test has also shown excellent sensitivity and specificity in the diagnosis of PCD/KS. [74],[80],[81]

Genetic diagnosis is another approach for assisting diagnosis of PCD/KS, but it is not yet popularly applied in the clinical setting. [77],[82],[83] In 2007, Morillas et al. [29] developed a clinical genetics analytical method that used DNAI1 and DNAH5 and involved a total of nine exons; the most common mutations in these two genes could be detected using this method, thereby promoting genetic diagnosis of PCD/KS. Given that the number of PCD/KS susceptibility genes and mutations that are being identified continues to increase, more extensive genetic screening should be performed in PCD/KS patients in the future.

It is important that incomplete and wrong diagnoses, such as diagnoses of ordinary sinusitis, pneumonia, asthma and tuberculosis, are avoided as much as possible; there are few specific indications during the early onset of PCD/KS, and several atypical presentations may occur. Bronchiectasis, for example, is an important indication of PCD. For a more definite diagnosis, some known causes of bronchiectasis, such as fibrosis, primary immunodeficiency, antitrypsin deficiency and some connective tissue diseases, must be ruled out. For adult patients, PCD can almost be ruled out if no bronchiectasis can be observed through high-resolution CT. [84]


  Treatment Top


McManus et al. [85] described faster development of respiratory symptoms before the age of 25 years, which worsens more slowly after this age. Therefore, treatment for PCD/KS should be initiated as early as possible, although there is currently no cure. For the treatment of bronchiectasis, the use of anti-infective therapies that promote discharge of secretions is indispensable. Since severe bronchiectasis may adversely affect the prognosis of the disease, pneumonoresection may be applied to treat local bronchiectasis without other visceral injury. For sinusitis, intranasal corticosteroids can be used in addition to drainage methods, and sensitive antibiotics should be cautiously adopted according to the results obtained in the culture of secretions. If conservative treatment is ineffective or if severe nasal polyps are accompanied by sinusitis, nasal endoscopic surgery can be considered. Effective treatment of sinusitis may relieve progression of bronchial and lung disease. Given the serious consequences that usually result from lung damage caused by repeated infections, such as respiratory insufficiency, pulmonary heart disease and heart failure; the therapeutic objectives for PCD/KS are to enhance prevention, facilitate prompt definitive diagnosis, avoid misdiagnosis, ensure active treatment, control infection and postpone development of lesions. [72],[86],[87],[88],[89] Adherence to these objectives will usually ensure a good prognosis. [90]

The sperm of infertile male patients with PCD/KS are usually immotile to varying degrees, or are even completely static and manifest defective morphology. Afflicted men generally have immotile ejaculated sperm and have almost no chance of achieving a spontaneous pregnancy. For these PCD/KS patients, assisted reproductive technology, including in vitro fertilization and ICSI, should be considered. In vitro fertilization could be a treatment option for patients when sperm motility is retained. [91] However, ICSI is currently the only treatment option for most PCD/KS patients. ICSI overcomes the factors related to impaired motility and bypasses the natural processes for fertilization. A number of reports have confirmed that it is possible to obtain healthy offspring in PCD/KS patients with the help of ICSI technique. [92],[93],[94],[95],[96],[97],[98],[99],[100],[101],[102][103]

The sperm for ICSI could be obtained from ejaculate, epididymis or testis. Although some authors reported successful pregnancies using sperm from ejaculate, [95],[104] it has been demonstrated that fertilization is improved with immotile testicular spermatozoa. [92] Until a better understanding of genetic control of PCD/KS is achieved, successful ICSI treatment will depend on sperm motility and should be individualized. [100] When using immotile sperm, differentiation between live and dead sperm is critical for the success of ICSI. [105] Some practical methods have been developed to differentiate and improve sperm motility. The hypoosmotic swelling test is widely used for identification of viable spermatozoa in a pool of immotile spermatozoa for ICSI. [102],[104] A noncontact diode laser assessment for sperm viability may be a useful alternative, especially in cases where the hypoosmotic swelling test is not informative. [106] A new sperm-screening method based on SYBR-14/propidium iodide flow cytometry has recently been reported. [107] To improve their motility, sperm with greater potential for fertilization may be obtained from ejaculated semen if patients undergo multiple ejaculations before providing the sample for in vitro fertilization/ICSI. [108] In addition, the velocity of sperm can be stimulated by treatment with pentoxifylline, a phosphodiesterase inhibitor. Employing this approach, a successful pregnancy and live delivery has been achieved. [109]

To date, it has been demonstrated that ICSI is an effective treatment modality for PCD/KS patients even with severest forms of male factor infertility. [95] However, it should be noted that the fertility of PCD/KS patients can still not be compared with that of the normal population, [28],[110] even though there have been many positive reports. In addition, clinical practitioners should be aware that the low fertility in male PCD/KS patients may involve a high incidence of aneuploid sperm, which is related to primary flagellum abnormalities. [111] Although the reported pregnancies and offspring are mostly normal and healthy, [95],[97],[98],[99],[100],[101],[102][103] it should be noted that the defects not only cause impaired fertility, but also increase the risk of genetic defects in the offspring. Therefore, genetic counseling may be mandatory for couples pursuing assisted reproductive technology and genetic assessment of sperm is highly recommended prior to clinical action. [110] To avoid undesirable cycles of treatment with a high possibility of failure or inheritance of genetic diseases, use of a semen donor may be a better option for some patients with severe defects.

In summary, PCD/KS severely affects the quality of life of patients, and the male infertility resulting from the disease is a major concern. More rapid, accurate, effective and economic means of diagnosis as well as treatments will hopefully be developed in the near future. The popularity of assisted reproductive technology will certainly benefit infertile couples affected by this disease. However, full understanding of the underlying molecular mechanisms of PCD/KS will require further studies.


  Author Contributions Top


YWS and LD drafted the manuscript, and PL revised it critically for important intellectual content. All authors have read and approved the final manuscript.


  Competing Interests Top


All authors declare no competing interests.

 
  References Top

1.Bent JP 3 rd , Smith RJ. Intraoperative diagnosis of primary ciliary dyskinesia. Otolaryngol Head Neck Surg 1997; 116: 64-7.  Back to cited text no. 1
    
2.Berdon WE, Willi U. Situs inversus, bronchiectasis, and sinusitis and its relation to immotile cilia: history of the diseases and their discoverers-Manes Kartagener and Bjorn Afzelius. Pediatr Radiol 2004; 34: 38-42.  Back to cited text no. 2
[PUBMED]    
3.Ortega HA, Vega Nde A, Santos BQ, Maia GT. Primary ciliary dyskinesia: considerations regarding six cases of Kartagener syndrome. J Bras Pneumol 2007; 33: 602-8.  Back to cited text no. 3
[PUBMED]    
4.Walter RJ, Malech HL, Oliver JM. Cell motility and microtubules in cultured fibroblasts from patients with Kartagener syndrome. Cell Motil 1983; 3: 185-97.  Back to cited text no. 4
[PUBMED]    
5.Rossman CM, Newhouse MT. Primary ciliary dyskinesia: evaluation and management. Pediatr Pulmonol 1988; 5: 36-50.  Back to cited text no. 5
[PUBMED]    
6.Cox DW, Talamo RC. Genetic aspects of pediatric lung disease. Pediatr Clin North Am 1979; 26: 467-80.  Back to cited text no. 6
[PUBMED]    
7.Afzelius BA, Eliasson R. Male and female infertility problems in the immotile-cilia syndrome. Eur J Respir Dis Suppl 1983; 127: 144-7.  Back to cited text no. 7
[PUBMED]    
8.Bartoloni L, Blouin JL, Pan Y, Gehrig C, Maiti AK, et al. Mutations in the DNAH11 (axonemal heavy chain dynein type 11) gene cause one form of situs inversus totalis and most likely primary ciliary dyskinesia. Proc Natl Acad Sci U S A 2002; 99: 10282-6.  Back to cited text no. 8
[PUBMED]    
9.Hulka GF. Head and neck manifestations of cystic fibrosis and ciliary dyskinesia. Otolaryngol Clin North Am 2000; 33: 1333-41, vii-viii.  Back to cited text no. 9
[PUBMED]    
10.Chuhwak EK. Kartagener syndrome in a Nigerian African--a case report and literature review. Niger J Med 2009; 18: 424-7.  Back to cited text no. 10
[PUBMED]    
11.Krishnamurthy S, Choudhary B, Rajesh NG, Ramesh A, Srinivasan S. Kartagener syndrome associated with mesangioproliferative glomerulonephritis. Paediatr Int Child Health 2012; 32: 116-8.  Back to cited text no. 11
[PUBMED]    
12.Jimenez Verdejo A, Martinez Torres JL, Palao Yago F, Tinaut Ranera J, Arrabal Martin M, et al. Renal cell carcinoma in patient with situs inversus and Kartagener syndrome. Actas Urol Esp 2000; 24: 169-72.  Back to cited text no. 12
    
13.Turkoglu K, Orhan K, Demir P, Karabulut B, Can-Karabulut DC. Primary ciliary dyskinesia: kartagener syndrome with central giant cell granuloma. A case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 110: e49-56.  Back to cited text no. 13
    
14.Horie M, Arai H, Noguchi S, Suzuki M, Sakamoto Y, et al. Kartagener syndrome with lung cancer and mediastinal tumor. Nihon Kokyuki Gakkai Zasshi 2010; 48: 375-8.  Back to cited text no. 14
[PUBMED]    
15.Yamashita S, Migita A, Hayashi K, Hirahara T, Kimura E, et al. Amyotrophic lateral sclerosis in a patient with Kartagener syndrome. Amyotroph Lateral Scler 2010; 11: 402-4.  Back to cited text no. 15
[PUBMED]    
16.Slodkowska J, Slupek A, Burakowski J, Bestry I, Filipecki S, et al. Kartagener syndrome and hemangiomatous proliferation of lung capillaries: case report and literature review. Pneumonol Alergol Pol 1996; 64: 217-24.  Back to cited text no. 16
    
17.Mittal V, Shah A. Situs inversus totalis: the association of Kartagener's syndrome with diffuse bronchiolitis and azoospermia. Arch Bronconeumol 2012; 48: 179-82.  Back to cited text no. 17
[PUBMED]    
18.Rebora ME, Cuneo JA, Marcos J, Marcos JC. Kartagener syndrome and rheumatoid arthritis. J Clin Rheumatol 2006; 12: 26-9.  Back to cited text no. 18
    
19.Pino Rivero V, Pardo Romero G, Iglesias Gonzalez RJ, Rodriguez Carmona M, del Castillo Beneyto F. Kartagener sindrome (primary ciliary dyskinesia). Report of a case and literature review. An Otorrinolaringol Ibero Am 2007; 34: 251-6.  Back to cited text no. 19
    
20.Baccetti B, Burrini AG, Capitani S, Collodel G, Moretti E, et al. Notulae seminologicae.1. New combinations of Kartagener's syndrome. Andrologia 1993; 25: 325-9.  Back to cited text no. 20
    
21.Imafuku T, Ogihara T, Kudo H, Hayashi K, Ohtake K, et al. Kartagener's syndrome associated with infundibular pulmonic stenosis, chronic renal failure and azoospermia: a report of a case. Jpn J Med 1986; 25: 195-8.  Back to cited text no. 21
    
22.Ramos Barselo E, Portillo Martin JA, Correas Gomez MA, del Valle Schaan JI, Gutierrez Banos JI, et al. Testicular seminoma in a patient with Kartagener's syndrome. Arch Esp Urol 2008; 61: 431-4.  Back to cited text no. 22
    
23.Crow TJ, Ball J, Bloom SR, Brown R, Bruton CJ, et al. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry 1989; 46: 1145-50.  Back to cited text no. 23
    
24.De Santi MM, Magni A, Valletta EA, Gardi C, Lungarella G. Hydrocephalus, bronchiectasis, and ciliary aplasia. Arch Dis Child 1990; 65: 543-4.  Back to cited text no. 24
    
25.Losa M, Ghelfi D, Hof E, Felix H, Fanconi S. Kartagener syndrome: an uncommon cause of neonatal respiratory distress? Eur J Pediatr 1995; 154: 236-8.  Back to cited text no. 25
    
26.Ferkol T, Leigh M. Primary ciliary dyskinesia and newborn respiratory distress. Semin Perinatol 2006; 30: 335-40.  Back to cited text no. 26
    
27.Ugwu RO, Eneh AU, Otaigbe BE. Kartagener syndrome: an unusual cause of respiratory distress in the newborn. Niger J Med 2006; 15: 444-7.  Back to cited text no. 27
    
28.Westlander G, Barry M, Petrucco O, Norman R. Different fertilization rates between immotile testicular spermatozoa and immotile ejaculated spermatozoa for ICSI in men with Kartagener's syndrome: case reports. Hum Reprod 2003; 18: 1286-8.  Back to cited text no. 28
    
29.Morillas HN, Zariwala M, Knowles MR. Genetic causes of bronchiectasis: primary ciliary dyskinesia. Respiration 2007; 74: 252-63.  Back to cited text no. 29
    
30.Stannard W, Rutman A, Wallis C, O'Callaghan C. Central microtubular agenesis causing primary ciliary dyskinesia. Am J Respir Crit Care Med 2004; 169: 634-7.  Back to cited text no. 30
    
31.Storm van's Gravesande K, Omran H. Primary ciliary dyskinesia: clinical presentation, diagnosis and genetics. Ann Med 2005; 37: 439-49.  Back to cited text no. 31
    
32.Chodhari R, Mitchison HM, Meeks M. Cilia, primary ciliary dyskinesia and molecular genetics. Paediatr Respir Rev 2004; 5: 69-76.  Back to cited text no. 32
    
33.Afzelius BA. A human syndrome caused by immotile cilia. Science 1976; 193: 317-9.  Back to cited text no. 33
    
34.Sleigh MA. Primary ciliary dyskinesia. Lancet 1981; 2: 476.  Back to cited text no. 34
    
35.Quintela C, Meireles C, Bettencourt MJ, Ribeirinho A, Bentes T. A rare case of primary ciliary dyskinesia with heterotaxy. Rev Port Pneumol 2009; 15: 115-20.  Back to cited text no. 35
    
36.Escudier E, Duquesnoy P, Papon JF, Amselem S. Ciliary defects and genetics of primary ciliary dyskinesia. Paediatr Respir Rev 2009; 10: 51-4.  Back to cited text no. 36
    
37.Lee L. Mechanisms of mammalian ciliary motility: insights from primary ciliary dyskinesia genetics. Gene 2011; 473: 57-66.  Back to cited text no. 37
    
38.Blouin JL, Meeks M, Radhakrishna U, Sainsbury A, Gehring C, et al. Primary ciliary dyskinesia: a genome-wide linkage analysis reveals extensive locus heterogeneity. Eur J Hum Genet 2000; 8: 109-18.  Back to cited text no. 38
    
39.Ishiguro T, Takayanagi N, Hijikata N, Yoshii Y, Yoneda K, et al. Primary ciliary dyskinesia. A case report and comparison with 4 previous cases. Nihon Kokyuki Gakkai Zasshi 2009; 47: 242-8.  Back to cited text no. 39
    
40.Geremek M, Zietkiewicz E, Diehl SR, Alizadeh BZ, Wijmenga C, et al. Linkage analysis localises a Kartagener syndrome gene to a 3.5 cM region on chromosome 15q24-25. J Med Genet 2006; 43: e1.  Back to cited text no. 40
    
41.Gutierrez-Roelens I, Sluysmans T, Jorissen M, Amyere M, Vikkula M. Localization of candidate regions for a novel gene for Kartagener syndrome. Eur J Hum Genet 2006; 14: 809-15.  Back to cited text no. 41
    
42.Geremek M, Schoenmaker F, Zietkiewicz E, Pogorzelski A, Diehl S, et al. Sequence analysis of 21 genes located in the Kartagener syndrome linkage region on chromosome 15q. Eur J Hum Genet 2008; 16: 688-95.  Back to cited text no. 42
    
43.Phillips DM, Jow WW, Goldstein M. Testis factors that may regulate gene expression: evidence from a patient with Kartagener's syndrome. J Androl 1995; 16: 158-62.  Back to cited text no. 43
    
44.Pennarun G, Escudier E, Chapelin C, Bridoux AM, Cacheux V, et al. Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Am J Hum Genet 1999; 65: 1508-19.  Back to cited text no. 44
    
45.Omran H, Haffner K, Volkel A, Kuehr J, Ketelsen UP, et al. Homozygosity mapping of a gene locus for primary ciliary dyskinesia on chromosome 5p and identification of the heavy dynein chain DNAH5 as a candidate gene. Am J Respir Cell Mol Biol 2000; 23: 696-702.  Back to cited text no. 45
    
46.Zariwala MA, Leigh MW, Ceppa F, Kennedy MP, Noone PG, et al. Mutations of DNAI1 in primary ciliary dyskinesia: evidence of founder effect in a common mutation. Am J Respir Crit Care Med 2006; 174: 858-66.  Back to cited text no. 46
    
47.Loges NT, Olbrich H, Fenske L, Mussaffi H, Horvath J, et al. DNAI2 mutations cause primary ciliary dyskinesia with defects in the outer dynein arm. Am J Hum Genet 2008; 83: 547-58.  Back to cited text no. 47
    
48.Guichard C, Harricane MC, Lafitte JJ, Godard P, Zaegel M, et al. Axonemal dynein intermediate-chain gene (DNAI1) mutations result in situs inversus and primary ciliary dyskinesia (Kartagener syndrome). Am J Hum Genet 2001; 68: 1030-5.  Back to cited text no. 48
    
49.Ibanez-Tallon I, Gorokhova S, Heintz N. Loss of function of axonemal dynein Mdnah 5 causes primary ciliary dyskinesia and hydrocephalus. Hum Mol Genet 2002; 11: 715-21.  Back to cited text no. 49
    
50.Pennarun G, Chapelin C, Escudier E, Bridoux AM, Dastot F, et al. The human dynein intermediate chain 2 gene (DNAI2): cloning, mapping, expression pattern, and evaluation as a candidate for primary ciliary dyskinesia. Hum Genet 2000; 107: 642-9.  Back to cited text no. 50
    
51.Bartoloni L, Blouin JL, Maiti AK, Sainsbury A, Rossier C, et al. Axonemal beta heavy chain dynein DNAH9: cDNA sequence, genomic structure, and investigation of its role in primary ciliary dyskinesia. Genomics 2001; 72: 21-33.  Back to cited text no. 51
    
52.Schwabe GC, Hoffmann K, Loges NT, Birker D, Rossier C, et al. Primary ciliary dyskinesia associated with normal axoneme ultrastructure is caused by DNAH11 mutations. Hum Mutat 2008; 29: 289-98.  Back to cited text no. 52
    
53.Mazor M, Alkrinawi S, Chalifa-Caspi V, Manor E, Sheffield VC, et al. Primary ciliary dyskinesia caused by homozygous mutation in DNAL1, encoding dynein light chain 1. Am J Hum Genet 2011; 88: 599-607.  Back to cited text no. 53
    
54.Mitchison HM, Schmidts M, Loges NT, Freshour J, Dritsoula A, et al. Mutations in axonemal dynein assembly factor DNAAF3 cause primary ciliary dyskinesia. Nat Genet 2012; 44: 381-9, S1-2.  Back to cited text no. 54
    
55.Duquesnoy P, Escudier E, Vincensini L, Freshour J, Bridoux AM, et al. Loss-of-function mutations in the human ortholog of Chlamydomonas reinhardtii ODA7 disrupt dynein arm assembly and cause primary ciliary dyskinesia. Am J Hum Genet 2009; 85: 890-6.  Back to cited text no. 55
    
56.Duriez B, Duquesnoy P, Escudier E, Bridoux AM, Escalier D, et al. A common variant in combination with a nonsense mutation in a member of the thioredoxin family causes primary ciliary dyskinesia. Proc Natl Acad Sci U S A 2007; 104: 3336-41.  Back to cited text no. 56
    
57.Omran H, Kobayashi D, Olbrich H, Tsukahara T, Loges NT, et al. Ktu/PF13 is required for cytoplasmic pre-assembly of axonemal dyneins. Nature 2008; 456: 611-6.  Back to cited text no. 57
    
58.Castleman VH, Romio L, Chodhari R, Hirst RA, de Castro SC, et al. Mutations in radial spoke head protein genes RSPH 9 and RSPH 4A cause primary ciliary dyskinesia with central-microtubular-pair abnormalities. Am J Hum Genet 2009; 84: 197-209.  Back to cited text no. 58
    
59.Panizzi JR, Becker-Heck A, Castleman VH, Al-Mutairi DA, Liu Y, et al. CCDC103 mutations cause primary ciliary dyskinesia by disrupting assembly of ciliary dynein arms. Nat Genet 2012; 44: 714-9.  Back to cited text no. 59
    
60.Kobayashi Y, Watanabe M, Okada Y, Sawa H, Takai H, et al. Hydrocephalus, situs inversus, chronic sinusitis, and male infertility in DNA polymerase lambda-deficient mice: possible implication for the pathogenesis of immotile cilia syndrome. Mol Cell Biol 2002; 22: 2769-76.  Back to cited text no. 60
    
61.Zariwala M, O'Neal WK, Noone PG, Leigh MW, Knowles MR, et al. Investigation of the possible role of a novel gene, DPCD, in primary ciliary dyskinesia. Am J Respir Cell Mol Biol 2004; 30: 428-34.  Back to cited text no. 61
    
62.Pennarun G, Bridoux AM, Escudier E, Dastot-Le Moal F, Cacheux V, et al. Isolation and expression of the human hPF20 gene orthologous to Chlamydomonas PF20: evaluation as a candidate for axonemal defects of respiratory cilia and sperm flagella. Am J Respir Cell Mol Biol 2002; 26: 362-70.  Back to cited text no. 62
    
63.Milara J, Armengot M, Mata M, Morcillo EJ, Cortijo J. Role of adenylate kinase type 7 expression on cilia motility: possible link in primary ciliary dyskinesia. Am J Rhinol Allergy 2010; 24: 181-5.  Back to cited text no. 63
    
64.Mata M, Lluch-Estelles J, Armengot M, Sarrion I, Carda C, et al. New adenylate kinase 7 (AK7) mutation in primary ciliary dyskinesia. Am J Rhinol Allergy 2012; 26: 260-4.  Back to cited text no. 64
    
65.Geremek M, Bruinenberg M, Zietkiewicz E, Pogorzelski A, Witt M, et al. Gene expression studies in cells from primary ciliary dyskinesia patients identify 208 potential ciliary genes. Hum Genet 2011; 129: 283-93.  Back to cited text no. 65
    
66.Maiti AK, Bartoloni L, Mitchison HM, Meeks M, Chung E, et al. No deleterious mutations in the FOXJ1 (alias HFH-4) gene in patients with primary ciliary dyskinesia (PCD). Cytogenet Cell Genet 2000; 90: 119-22.  Back to cited text no. 66
    
67.Neesen J, Drenckhahn JD, Tiede S, Burfeind P, Grzmil M, et al. Identification of the human ortholog of the t-complex-encoded protein TCTE3 and evaluation as a candidate gene for primary ciliary dyskinesia. Cytogenet Genome Res 2002; 98: 38-44.  Back to cited text no. 67
    
68.Serapinas D, Staikuniene J, Barkauskiene D, Jackute J, Sakalauskas R. An unusual regression of the symptoms of kartagener syndrome. Arch Bronconeumol 2013; 49: 28-30.  Back to cited text no. 68
    
69.Leigh MW, Pittman JE, Carson JL, Ferkol TW, Dell SD, et al. Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med 2009; 11: 473-87.  Back to cited text no. 69
    
70.Meeks M, Bush A. Primary ciliary dyskinesia (PCD). Pediatr Pulmonol 2000; 29: 307-16.  Back to cited text no. 70
    
71.Baccetti B, Capitani S, Collodel G, Di Cairano G, Gambera L, et al. Genetic sperm defects and consanguinity. Hum Reprod 2001; 16: 1365-71.  Back to cited text no. 71
    
72.Casanova MS, Tuji FM, Yoo HJ, Haiter-Neto F. Kartagener syndrome. Dentomaxillofac Radiol 2006; 35: 386-9.  Back to cited text no. 72
    
73.Silkoff PE. Nasal nitric oxide: clue to a diagnosis of ciliary dyskinesia. Chest 2004; 126: 1013-4.  Back to cited text no. 73
    
74.Marthin JK, Mortensen J, Pressler T, Nielsen KG. Pulmonary radioaerosol mucociliary clearance in diagnosis of primary ciliary dyskinesia. Chest 2007; 132: 966-76.  Back to cited text no. 74
    
75.Cichocka-Jarosz E, Jedynak-Wasowicz U, Glodzik I, Lis G, Pietrzyk JJ. Primary ciliary dyskinesia in highlights of consensus statement. Presentation of pediatric cases. Przegl Lek 2010; 67: 135-40.  Back to cited text no. 75
    
76.Greenstone MA, Dewar A, Cole PJ. Ciliary dyskinesia with normal ultrastructure. Thora× 1983; 38: 875-6.  Back to cited text no. 76
    
77.Leigh MW, Zariwala MA, Knowles MR. Primary ciliary dyskinesia: improving the diagnostic approach. Curr Opin Pediatr 2009; 21: 320-5.  Back to cited text no. 77
    
78.Degano B, Valmary S, Serrano E, Brousset P, Arnal JF. Expression of nitric oxide synthases in primary ciliary dyskinesia. Hum Pathol 2011; 42: 1855-61.  Back to cited text no. 78
    
79.Leigh MW, O'Callaghan C, Knowles MR. The challenges of diagnosing primary ciliary dyskinesia. Proc Am Thorac Soc 2011; 8: 434-7.  Back to cited text no. 79
    
80.Taylor RE. Abnormal mucociliary transport study in a patient with Kartagener syndrome. Clin Nucl Med 2006; 31: 240-2.  Back to cited text no. 80
    
81.Chen YW, Chang CC, Lai YC, Lu CY, Dai ZK. Evaluation of residual functional lung volume on Tc-99m DTPA aerosol ventilation and Tc-99m MAA perfusion scintigraphy in primary ciliary dyskinesia (Kartagener syndrome). Clin Nucl Med 2008; 33: 901-2.  Back to cited text no. 81
    
82.Barbato A, Frischer T, Kuehni CE, Snijders D, Azevedo I, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J 2009; 34: 1264-76.  Back to cited text no. 82
    
83.Zariwala MA, Omran H, Ferkol TW. The emerging genetics of primary ciliary dyskinesia. Proc Am Thorac Soc 2011; 8: 430-3.  Back to cited text no. 83
    
84.Kennedy MP, Noone PG, Leigh MW, Zariwala MA, Minnix SL, et al. High-resolution CT of patients with primary ciliary dyskinesia. AJR Am J Roentgenol 2007; 188: 1232-8.  Back to cited text no. 84
    
85.McManus IC, Mitchison HM, Chung EM, Stubbings GF, Martin N. Primary ciliary dyskinesia (Siewert's/Kartagener's syndrome): respiratory symptoms and psycho-social impact. BMC Pulm Med 2003; 3: 4.  Back to cited text no. 85
    
86.Rachinskii SV, Volkov IK, Sereda EV, Alekseevskikh IuG, Lukina OF, et al. The Zivert-Kartagener syndrome in children. Probl Tuberk 1993; 6: 19-22.  Back to cited text no. 86
    
87.Wessels MW, den Hollander NS, Willems PJ. Mild fetal cerebral ventriculomegaly as a prenatal sonographic marker for Kartagener syndrome. Prenat Diagn 2003; 23: 239-42.  Back to cited text no. 87
    
88.D'Auria E, Palazzo S, Argiro S, El OS, Riva E. Primary ciliary dyskinesia: clinical and genetic aspects. Pediatr Med Chir 2012; 34: 117-22.  Back to cited text no. 88
    
89.Gupta S, Handa KK, Kasliwal RR, Bajpai P. A case of Kartagener's syndrome: importance of early diagnosis and treatment. Indian J Hum Genet 2012; 18: 263-7.  Back to cited text no. 89
    
90.Tkebuchava T, von Segesser LK, Niederhauser U, Bauersfeld U, Turina M. Cardiac surgery for Kartagener syndrome. Pediatr Cardiol 1997; 18: 72-3.  Back to cited text no. 90
    
91.Kay VJ, Irvine DS. Successful in-vitro fertilization pregnancy with spermatozoa from a patient with Kartagener's syndrome: case report. Hum Reprod 2000; 15: 135-8.  Back to cited text no. 91
    
92.Nijs M, Vanderzwalmen P, Vandamme B, Segal-Bertin G, Lejeune B, et al. Fertilizing ability of immotile spermatozoa after intracytoplasmic sperm injection. Hum Reprod 1996; 11: 2180-5.  Back to cited text no. 92
    
93.Olmedo SB, Nodar F, Chillik C, Chemes HE. Successful intracytoplasmic sperm injection with spermatozoa from a patient with dysplasia of the fibrous sheath and chronic respiratory disease. Hum Reprod 1997; 12: 1497-9.  Back to cited text no. 93
    
94.Papadimas J, Tarlatzis BC, Bili H, Sotiriadis T, Koliakou K, et al. Therapeutic approach of immotile cilia syndrome by intracytoplasmic sperm injection: a case report. Fertil Steril 1997; 67: 562-5.  Back to cited text no. 94
    
95.von Zumbusch A, Fiedler K, Mayerhofer A, Jessberger B, Ring J, et al. Birth of healthy children after intracytoplasmic sperm injection in two couples with male Kartagener's syndrome. Fertil Steril 1998; 70: 643-6.  Back to cited text no. 95
    
96.Olmedo SB, Rawe VY, Nodar FN, Galaverna GD, Acosta AA, et al. Pregnancies established through intracytoplasmic sperm injection (ICSI) using spermatozoa with dysplasia of fibrous sheath. Asian J Androl 2000; 2: 125-30.  Back to cited text no. 96
    
97.Cayan S, Conaghan J, Schriock ED, Ryan IP, Black LD, et al. Birth after intracytoplasmic sperm injection with use of testicular sperm from men with Kartagener/immotile cilia syndrome. Fertil Steril 2001; 76: 612-4.  Back to cited text no. 97
    
98.Abu-Musa A, Nassar A, Usta I. In vitro fertilization in two patients with Kartagener's syndrome and infertility. Gynecol Obstet Invest 2008; 65: 29-31.  Back to cited text no. 98
    
99.Kordus RJ, Price RL, Davis JM, Whitman-Elia GF. Successful twin birth following blastocyst culture of embryos derived from the immotile ejaculated spermatozoa from a patient with primary ciliary dyskinesia: a case report. J Assist Reprod Genet 2008; 25: 437-43.  Back to cited text no. 99
    
100.Matsumoto Y, Goto S, Hashimoto H, Kokeguchi S, Shiotani M, et al. A healthy birth after intracytoplasmic sperm injection using ejaculated spermatozoa from a patient with Kartagener's syndrome. Fertil Steril 2010; 93: 2074.e17-9.  Back to cited text no. 100
    
101.Vicdan K, Akarsu C, Vicdan A, Sozen E, Buluc B, et al. Birth of a healthy boy using fresh testicular sperm in a patient with Klinefelter syndrome combined with Kartagener syndrome. Fertil Steril 2011; 96: 577-9.  Back to cited text no. 101
    
102.Geber S, Lemgruber M, Taitson PF, Valle M, Sampaio M. Birth of healthy twins after intracytoplasmic sperm injection using ejaculated immotile spermatozoa from a patient with Kartagener's syndrome. Andrologia 2012; 44 Suppl 1: 842-4.  Back to cited text no. 102
    
103.McLachlan RI, Ishikawa T, Osianlis T, Robinson P, Merriner DJ, et al. Normal live birth after testicular sperm extraction and intracytoplasmic sperm injection in variant primary ciliary dyskinesia with completely immotile sperm and structurally abnormal sperm tails. Fertil Steril 2012; 97: 313-8.  Back to cited text no. 103
    
104.Peeraer K, Nijs M, Raick D, Ombelet W. Pregnancy after ICSI with ejaculated immotile spermatozoa from a patient with immotile cilia syndrome: a case report and review of the literature. Reprod Biomed Online 2004; 9: 659-63.  Back to cited text no. 104
    
105.Shibahara H, Hamada Y, Hasegawa A, Wakimoto E, Toji H, et al. Relationship between the sperm motility index assessed by the sperm quality analyzer and the outcome of intracytoplasmic sperm injection. J Assist Reprod Genet 1999; 16: 540-5.  Back to cited text no. 105
    
106.Gerber PA, Kruse R, Hirchenhain J, Krussel JS, Neumann NJ. Pregnancy after laser-assisted selection of viable spermatozoa before intracytoplasmatic sperm injection in a couple with male primary cilia dyskinesia. Fertil Steril 2008; 89: 1826.e9-12.  Back to cited text no. 106
    
107.Niu ZH, Huang XF, Jia XF, Zheng J, Yuan Y, et al. A sperm viability test using SYBR-14/propidium iodide flow cytometry as a tool for rapid screening of primary ciliary dyskinesia patients and for choosing sperm sources for intracytoplasmic sperm injection. Fertil Steril 2011; 95: 389-92.  Back to cited text no. 107
    
108.Ron-El R, Strassburger D, Friedler S, Komarovsky D, Bern O, et al. Repetitive ejaculation before intracytoplasmic sperm injection in patients with absolute immotile spermatozoa. Hum Reprod 1998; 13: 630-3.  Back to cited text no. 108
    
109.Hattori H, Nakajo Y, Ito C, Toyama Y, Toshimori K, et al. Birth of a healthy infant after intracytoplasmic sperm injection using pentoxifylline-activated sperm from a patient with Kartagener's syndrome. Fertil Steril 2011; 95: 2431.e9-11.  Back to cited text no. 109
    
110.Abu-Musa A, Hannoun A, Khabbaz A, Devroey P. Failure of fertilization after intracytoplasmic sperm injection in a patient with Kartagener's syndrome and totally immotile spermatozoa: case report. Hum Reprod 1999; 14: 2517-8.  Back to cited text no. 110
    
111.Rives N, Mousset-Simeon N, Mazurier S, Mace B. Primary flagellar abnormality is associated with an increased rate of spermatozoa aneuploidy. J Androl 2005; 26: 61-9.  Back to cited text no. 111
    



This article has been cited by
1 Primary Ciliary Dyskinesia: An Update on Clinical Aspects, Genetics, Diagnosis, and Future Treatment Strategies
Virginia Mirra,Claudius Werner,Francesca Santamaria
Frontiers in Pediatrics. 2017; 5
[Pubmed] | [DOI]
2 New insights in primary ciliary dyskinesia
Ana Reula,JS Lucas,Antonio Moreno-Galdó,Teresa Romero,Xavier Milara,Carmen Carda,Manuel Mata-Roig,Amparo Escribano,Francisco Dasi,Miguel Armengot-Carceller
Expert Opinion on Orphan Drugs. 2017; : 1
[Pubmed] | [DOI]
3 Assessment of ciliary phenotype in primary ciliary dyskinesia by micro-optical coherence tomography
George M. Solomon,Richard Francis,Kengyeh K. Chu,Susan E. Birket,George Gabriel,John E. Trombley,Kristi L. Lemke,Nikolai Klena,Brett Turner,Guillermo J. Tearney,Cecilia W. Lo,Steven M. Rowe
JCI Insight. 2017; 2(5)
[Pubmed] | [DOI]
4 Recommendations for aetiological diagnosis of bronchiectasis
Revista Portuguesa de Pneumologia (English Edition). 2016;
[Pubmed] | [DOI]
5 Left middle lobectomy for bronchiectasis in a patient with Kartagener syndrome: a case report
Haiping Lin,Ziang Cao,Xiaojing Zhao,Qing Ye
Journal of Cardiothoracic Surgery. 2016; 11(1)
[Pubmed] | [DOI]
6 Whole exome sequencing in recurrent early pregnancy loss
Ying Qiao,Jiadi Wen,Flamingo Tang,Sally Martell,Naomi Shomer,Peter C.K. Leung,Mary D. Stephenson,Evica Rajcan-Separovic
Molecular Human Reproduction. 2016; : gaw008
[Pubmed] | [DOI]
7 The axoneme: the propulsive engine of spermatozoa and cilia and associated ciliopathies leading to infertility
Richard W. Linck,Hector Chemes,David F. Albertini
Journal of Assisted Reproduction and Genetics. 2016; 33(2): 141
[Pubmed] | [DOI]
8 Teratozoospermia: spotlight on the main genetic actors in the human
C. Coutton,J. Escoffier,G. Martinez,C. Arnoult,P. F. Ray
Human Reproduction Update. 2015; 21(4): 455
[Pubmed] | [DOI]
9 Expression profiles of NPHP1 in the germ cells in the semen of men with male factor infertility
A. N. Devi,T. R. Anil Kumar,S. M. Pillai,K. Jayakrishnan,P. G. Kumar
Andrology. 2015; 3(4): 685
[Pubmed] | [DOI]
10 Eponyms in andrology
Khalid Al Aboud,Daifullah Al Aboud,Sameer Munshi,Ali Halawi
Basic and Clinical Andrology. 2014; 24(1): 7
[Pubmed] | [DOI]
11 Genetics, diagnosis and future treatment strategies for primary ciliary dyskinesia
Mary Leigh Anne Daniels,Peadar G Noone
Expert Opinion on Orphan Drugs. 2014; : 1
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Incidence and Cl...
Pathophysiology ...
Diagnosis
Treatment
Author Contributions
Competing Interests
References

 Article Access Statistics
    Viewed3335    
    Printed102    
    Emailed0    
    PDF Downloaded486    
    Comments [Add]    
    Cited by others 11    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]